Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.
Journal of the American College of Cardiology|September 26, 2009
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky, Gregg W Stone, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES StudySorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
The American Journal of Cardiology|July 6, 2010
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)Ajay J Kirtane, Helen Parise, Roxana Mehran, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
American Heart Journal|September 10, 2018
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stentsChristine J Chung, Ajay J Kirtane, Yiran Zhang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky, Yoshihiro Tsuchiya, Micheal Brener, et al.
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Lancet (London, England)|July 30, 2013
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyGregg W Stone, Bernhard Witzenbichler, Giora Weisz, et al.
Science Advances|May 16, 2019
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivoSantiago G Lago, Jakub Tomasik, Geertje F van Rees, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|August 30, 2008
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialHarvey D White, E Magnus Ohman, A Michael Lincoff, et al.
Journal of the American College of Cardiology|September 26, 2009
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky, Gregg W Stone, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|July 4, 2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES StudySorin J Brener, Ajay J Kirtane, Thomas D Stuckey, et al.
The American Journal of Cardiology|July 6, 2010
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)Ajay J Kirtane, Helen Parise, Roxana Mehran, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
American Heart Journal|September 10, 2018
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stentsChristine J Chung, Ajay J Kirtane, Yiran Zhang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 20, 2008
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trialAlexandra J Lansky, Yoshihiro Tsuchiya, Micheal Brener, et al.
Circulation|November 28, 2013
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) studyBernhard Witzenbichler, Akiko Maehara, Giora Weisz, et al.
Lancet (London, England)|July 30, 2013
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyGregg W Stone, Bernhard Witzenbichler, Giora Weisz, et al.
Science Advances|May 16, 2019
Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivoSantiago G Lago, Jakub Tomasik, Geertje F van Rees, et al.
Pageof 17